期刊文献+

非瓣膜病心房颤动的抗凝治疗 被引量:6

下载PDF
导出
摘要 非瓣膜病心房颤动(NVAF)患者卒中的危险性较高。文章就NVAF的流行病学特征、危险因素分层、心脏复律的抗凝治疗、抗凝治疗的合理强度及注意事项等进行了综述。
作者 卢林 黄如训
出处 《国外医学(脑血管疾病分册)》 2002年第5期345-347,共3页 Foreign Medical Sciences Cerebrovascular Diseases
  • 相关文献

参考文献16

  • 1Ezekowitz MD, Levine JA. Preventing stroke in patients with atrial fibrillation. JAMA, 1999, 281(19): 1830-1835.
  • 2Feinberg WM, Cornell ES, Nightingale SD, et al. Relationship between prothrombin activation fragment F1.2 and international normalized ratin in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Stroke, 1997, 28(6): 1101-1106.
  • 3Fihn SD, Callahan CM, Martin DC, et al. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med,1996, 124(11): 970-979.
  • 4Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fiorillation. The Copenhagen AFASAK study. Lancet, 1989, 1(8631): 175-179.
  • 5Hart RG, Pearce LA, McBride R, et al. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012participants in the SPAF Ⅰ-Ⅲ clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke, 1999, 30(6): 1223-1229.
  • 6Singer DE, Hughes RA, Gress DR, et al. The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study. Am Heart J, 1992,124(6): 1567-1573.
  • 7Connolly SJ, Laupacis A, Gent M, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol, 1991, 18(2): 349-355.
  • 8Hart RG, Pearce LA, McBride R, et al. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012participants in the SPAF Ⅰ-Ⅲ clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke, 1999, 30(6): 1223-1229
  • 9Gullov AL, Koefoed BG, Petersen P. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study.Atrial Fibrillation Aspirin and Anticoagulation. Arch Intern Med, 1999,159(12): 1322-1328.
  • 10Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet, 1993, 342(8882): 1255-1262.

同被引文献37

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部